Our Mission
To provide a vibrant forum for interdisciplinary research, professional development, mentorship, networking, and advocacy for all who work with patients undergoing transplantation and cellular therapies.
Transplantation and cellular therapies are increasingly becoming standard of care for some malignant andnon-malignant disorders. The intensive nature of treatment accompanied by an extended recovery and potential medical complications result in significant psychosocial needs among patients and their caregivers.
The transplantation and cellular therapy (TCT) SIG at APOS is poised to develop and organize resources that could advance the psychosocial care and science of this vulnerable population while fostering collaboration and career development among clinicians and researchers who care for this population.
Meet Our Chairs
Hermioni L. Amonoo,
MD, MPP, MPH
Hermioni L. Amonoo, MD, MPP, MPH is the Carol C. Nadelson, MD Endowed Chair in Psychiatry at the Brigham and Women’s Hospital (BWH) and Associate Professor at Harvard Medical School. She is a physician-scientist in the Departments of Psychiatry and Supportive Oncology at BWH and the Dana-Farber Cancer Institute (DFCI), where she directs the Well-being and Cancer Research Program. She is a graduate of Harvard Medical School, Harvard Kennedy School of Government, Harvard Chan School of Public Health, the Massachusetts General Hospital Adult Psychiatry Residency Training Program, and the BWH/DFCI Consultation-Liaison Psychiatry/Psychosocial Oncology Fellowship Training Program. Her research focuses on developing patient-centered, cost-effective, and scalable psychosocial interventions for patients with cancer and their caregivers. Her work resulted in >100 peer-reviewed journal publications and has consistently received funding from Harvard Medical School, Brigham Research Institute, the National Cancer Institute (NCI), the National Institute of Health (NIH), and several foundations including the Oppenheimer Family Foundation, the American Society for Hematology, the Robert Wood Johnson Foundation, and the Doris Duke Charitable Foundation.
Damien Miran, MD
Damien Miran, MD, is a consultation-liaison psychiatrist specializing in psychosocial oncology and serves as Clinical Director of the Dana-Farber Inpatient Psychiatry Consult Service. He is Course Director for the Harvard Medical School CME program Psychosocial Oncology: What to Expect When Caring for an Oncology Patient, launched in 2025, and his teaching has been recognized with the Brigham and Women’s Hospital/Dana-Farber Cancer Institute C-L Fellowship Faculty Teaching Award in 2023 and 2025. Dr. Miran completed residency in the Harvard Longwood Psychiatry Residency Training Program at Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital, followed by C-L Psychiatry fellowship on the psycho-oncology track at Brigham and Women’s Hospital, Harvard Medical School, and Dana-Farber Cancer Institute. His clinical and academic work focuses on demoralization, medical education, and the psychiatric care of patients with cancer.
We Welcome New SIG Members
One of the APOS member benefits is to join the conversation on Groupsite with any of the 10 Special Interest Groups (SIGs). This is a very engaging conversation platform and the Executive Office is happy to help you navigate this platform and help you set up your profile to begin networking.
